Ameliorative effect of riboflavin on the cisplatin induced nephrotoxicity and hepatotoxicity under photoillumination

Food and Chemical Toxicology

Volumn 48, Issue 8-9, 2010, Pages 2052-2058

  Hassan, I ^a   Chibber, S ^a   Naseem, I ^a  

^a ALIGARH MUSLIM UNIVERSITY   (India)

Author keywords

Cisplatin; Hepatotoxicity; Nephrotoxicity; Oxidative stress; Photoillumination; Riboflavin

Indexed keywords

ALKALINE PHOSPHATASE; CARBONYL DERIVATIVE; CATALASE; CISPLATIN; COPPER ZINC SUPEROXIDE DISMUTASE; GLUTATHIONE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; MALONALDEHYDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; RIBOFLAVIN; ALANINE AMINOTRANSFERASE; ANTINEOPLASTIC AGENT; ANTIOXIDANT; ASPARTATE AMINOTRANSFERASE; PHOTOSENSITIZING AGENT;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ILLUMINATION; LIPID PEROXIDATION; LIVER TOXICITY; MALE; MOUSE; NEPHROTOXICITY; NONHUMAN; OXIDATIVE STRESS; UREA BLOOD LEVEL; UREA NITROGEN BLOOD LEVEL; WEIGHT REDUCTION; ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD; BODY WEIGHT; CHEMICALLY INDUCED; DRUG EFFECTS; DRUG-INDUCED LIVER INJURY; KIDNEY DISEASES; KIDNEY FUNCTION TEST; LIGHT; LIVER FUNCTION TEST; METABOLISM; OXIDATION REDUCTION REACTION; TOXICITY;

ALANINE TRANSAMINASE; ANIMALS; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; ASPARTATE AMINOTRANSFERASES; BLOOD UREA NITROGEN; BODY WEIGHT; CISPLATIN; DRUG-INDUCED LIVER INJURY; KIDNEY DISEASES; KIDNEY FUNCTION TESTS; LIGHT; LIPID PEROXIDATION; LIVER FUNCTION TESTS; MALE; MICE; OXIDATION-REDUCTION; PHOTOSENSITIZING AGENTS; RIBOFLAVIN;

MUS;

EID: 77955049140     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2010.05.004     Document Type: Article

References (44)

1. Aebi H. Catalase in vitro. Meth. Enzymol. 1984, 105:121-126.
2. Antunes L.M.G., Darin J.D.C., Biachi M.L.P. Protective effects of vitamin C against cisplatin-induced nephrotoxicity and lipid peroxidation in adult rats. Parmacol. Res. 2000, 41:405-411.
3. Atessahin A., Karahan I., Turk G., Gur S., Yilmaz S., Ceribasi A.O. Protective role of lycopene on cisplatin-induced changes in sperm characteristics, testicular damage and oxidative stress in rats. Reprod. Toxicol. 2006, 21:945-955.
4. Beuge J.A., Aust S.D. Microsomal lipid peroxidation. Meth. Enzymol. 1978, 52:302-310.
5. Carlberg I., Mannervik B. Glutathione reductase. Meth. Enzymol. 1985, 113:484-490.
6. Cayir K., Karadeniz A., Yildirim A., Kalkan Y., Karakoc A., Keles M., Tekin S.B. Protective effects of l-carnitine against cisplatin-induced liver and kidney oxidant injury in rats. Cent. Eur. J. Med. 2009, 4(2):184-191.
7. Corde S., Balosso J., Elleaume H., Renier M., Joubert A., Biston M.C., Adam J.F., Charvet A.M., Le Bas J.F., Esteve F., Foray N. Synchrotron photoactivation of cisplatin elicits extra number of DNA breaks that stimulate RAD-51-mediated repair pathways. Cancer Res. 2003, 63(12):3221-3227.
8. Cosa G. Photodegradation and photosensitization in pharmaceutical products: assessing drug phototoxicity. Pure Appl. Chem. 2004, 76:263-275.
9. Cui Z., Huang Y., Mo Q., Wang X., Quian K. Inactivation of lymphocytes in blood products using riboflavin photochemical treatment with visible light. Photochem. Photobiol. 2008, 84:1195-1200.
10. de Souza Queiroz K.C., Zambuzzi W.F., de Souza A.C.S., da Silva R.A., Machado D., Justo G.Z., Carvalho H.F., Peppelenbosch M.P., Ferreira C.V. A possible anti-proliferative and anti-metastatic effect of irradiated riboflavin in solid tumors. Cancer Lett. 2007, 258:126-134.
11. de Souza A.C.S., Kodach L., Gadelha F.R., Bos C.L., Cavagis A.D.M., Aoyama H., Peppelenbosch M.P., Ferreira C.V. A promising action of riboflavin as a mediator of leukemia cell death. Apoptosis 2006, 11(10):1761-1771.
12. Edwards A.M., Silva E., Jofre B., Becker M.I., De Ioannes A.E. Visible light effects on tumoral cells in a culture medium enriched with tryptophan and riboflavin. J. Photochem. Photobiol. B: Biol. 1994, 24:179-186.
13. Eubanks L.M., Dickerson T.J., Janda K.D. Vitamin B2-mediated cellular photoinhibition of botulinum neurotoxin A. FEBS Lett. 2005, 579:5361-5364.
14. Fichtinger-Schepman A.M.J., Van Der Veer J.L., Den Hartog J.H.J., Lohman P.H.M., Reedijk J. Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification and quantification. Biochemistry 1985, 24:707-713.
15. Gottfried M., Ramlau R., Krzakowski M., Ziolo G., Olechnowicz H. Cisplatin-based three drugs combination (NIP) as induction and adjuvant treatment in locally advanced non-small cell lung cancer: final results. J. Thorac. Oncol. 2008, 3:152-157.
16. Habig W.H., Pabst M.J., Jokoby W.B. Glutathione S-transferase: the first enzymatic step in mercapturic acid formation. J. Biol. Chem. 1974, 249(22):7130-7139.
17. Hah S.S., Stivers K.M., de Vere White R.W., Henderson P.T. Kinetics of carboplatin-DNA binding in genomic DNA and bladder cancer cells are determined by accelerator mass spectrometry. Chem. Res. Toxicol. 2006, 19(5):622-626.
18. Hanigan M.H., Lykissa E.D., Townsend D.M., Ou C.N., Barrios R., Liebermant M.W. γ-Glutamyl transpeptidase deficient mice are resistant to the nephrotoxic effects of cisplatin. Am. J. Pathol. 2001, 159:1889-1894.
19. Husain E., Naseem I. Riboflavin mediated cellular photoinhibition of cisplatin-induced oxidative DNA breakage in mice keratinocytes. Photodermatol. Photoimmunol. Photomed. 2008, 24(6):301-307.
20. Iseri S., Ercan F., Gedik N., Yuksel M., Alican I. Simvastatin attenuates cisplatin-induced kidney and liver damage in rats. Toxicology 2007, 230:256-264.
21. Jazzer M.M., Naseem I. Enhanced protein degradation by photoilluminated riboflavin in the presence of Cu(II). Biochem. Mol. Biol. Int. 1994, 34:883-895.
22. Jazzer M.M., Naseem I. Genotoxicity of photoilluminated riboflavin in the presence of Cu(II). Free Radic. Biol. Med. 1996, 21:7-14.
23. Jollow D.J., Mitchell J.R., Zampaglione N., Gillette J.R. Bromobenzene induced liver necrosis: protective role of glutathione and evidence for 3,4-bromobenzene oxide as hepatotoxic metabolite. Pharmacology 1974, 11:151-169.
24. Kumari M.V., Yoneda T., Hiramatsu M. Scavenging activity of beta catechin on reactive oxygen species generated by photosensitization of riboflavin. Biochem. Mol. Biol. Int. 1996, 38:1163-1170.
25. Levine R.L., Williams J., Stadman E.R., Shacter E. Carbonyl assay for determination of oxidatively modified proteins. Meth. Enzymol. 1994, 233:346-357.
26. Liao Y., Lu X., Lu C., Li G., Jin Y., Tang H. Selection of agents for prevention of cisplatin-induced hepatotoxicity. Pharmcol. Res. 2008, 57:125-131.
27. Marklund S., Marklund G. Involvement of superoxide anion radical in the auto oxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur. J. Biochem. 1974, 47:469-474.
28. Martin N.M., Santos N.A.G., Curti C., Bianchi M.L.P., Santos A.C. Cisplatin induces mitochondrial oxidative stress with resultant energetic metabolism impairment, membrane rigidification and apoptosis in rat liver. J. Appl. Toxicol. 2008, 28:337-344.
29. Mc Keage M.J. Comparative adverse effect profiles of platinum drugs. Drug Saf. 1995, 13(4):228-244.
30. Naziroglu M., Karaoglu A., Aksoy A.O. Selenium and high dose vitamin E administration protects cisplatin-induced oxidative damage to renal, liver and lens tissues in rats. Toxicology 2004, 195:221-230.
31. Perra A., Jackson H., Sharma H.L., McAuliffe C.A., Fox B.W. A comparative binding of platinum antitumor compounds to plasma proteins in rats (in vivo) and mouse (in vitro). Chem. Biol. Interact. 1992, 85:199-213.
32. Sato K., Sakakibara N., Hasegawa K., Minami H., Tsuji T. A preliminary report of the treatment of blue nevus with dermal injection of riboflavin and exposure to near ultra violet/visible radiation (ribophototherapy). J. Dermatol. Sci. 2000, 23:22-26.
33. Sedalk J., Lindsay R.H. Estimation of total, protein-bound and non-protein sulfhydryl groups in tissues with Ellman's reagent. Anal. Biochem. 1968, 25:192-205.
34. Shah S.V., Kempson S.A., Northrup T.E., Dousa T.P. Renal adaptation to a low phosphate diet in rats. J. Clin. Invest. 1979, 64:955-966.
35. Srivastava R.C., Farookh A., Ahmad N., Misra M., Hasan S.K., Hussain M.M. Evidence for the involvement of nitric oxide in cisplatin induced toxicity in rats. Biometal 1996, 9:139-142.
36. Suo Z., Lippard S.J., Johnson K.A. Single d(GpG) cis-diammineplatinum(II) adduct-induced inhibition of DNA polymerization. Biochemistry 1999, 38:715-726.
37. Sweetman S.C. Antineoplastic and immunosuppressant. The Complete Drug Reference 2002, Pharmaceutical Press, London, UK, pp. 516-517. 33rd ed.
38. Tarladacalisir Y.T., Kanter M., Uygun M. Protective effects of vitamin C on cisplatin-induced renal damage: a light and electron microscopic study. Renal Failure 2008, 30:1-8.
39. Tikoo K., Bhatt D.K., Gaikwad A.B., Sharma V., Kabra D.G. Differential effects of tannic acid on cisplatin induced nephrotoxicity in rats. FEBS Lett. 2007, 581:2027-2035.
40. Turk G., Atessahin A., Sonmez M., Ceribasi A.O., Yuce A. Improvement of cisplatin-induced injuries to sperm quality, the oxidant-antioxidant system, and the histological structure of the rat testis by ellagic acid. Fertil. Steril. 2008, 89:1474-1481.
41. Xiao T., Choudhary S., Zhang W., Ansari N.H., Salahuddin A. Possible role of oxidative stress in cisplatin-induced apoptosis in LLC-PK1 cells. J. Toxicol. Environ. Health A 2003, 66(5):469-479.
42. Yoshida M., Fukuda A., Hara M., Terada A., Kitanaka Y., Owada S. Melatonin prevents the increase in hydroxyl radical spin trap adduct formation caused by the addition of cisplatin in vitro. Life Sci. 2003, 72:1773-1780.
43. Younes M., Siegers C.P. Mechanistic aspects of enhanced lipid peroxidation following glutathione depletion in vivo. Chem. Biol. Interact. 1981, 34:257-266.
44. Zicca A., Cafaggi S., Mariggio M.A., Vannozzi M.O., Ottone M., Bocchini V., Caviglioli G., Viale M. Reduction of cisplatin hepatotoxicity by procainamide hydrochloride in rats. Eur. J. Pharmacol. 2002, 442:265-272.